Astrazeneca (AZN) EPS & PE Ratio History
Current and historical earning per share (EPS) and price to earnings (PE) ratio for Astrazeneca (AZN) over the last 10 years. The current PE ratio for Astrazeneca as of August 16, 2017 is 6.62.
|Medical||Large Cap Pharmaceutical||$73.568B||$23.002B|
|AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.|